People · Operator
Named in public records as an officer, director or promoter · active 2012–2021 · Pharmaceuticals, Business Services, Biotechnology, Agriculture
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aeolus Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $18.5M | $209.0M | 2012 |
| Bye UAS, Inc. | — | Business Services | Seed | $7.5M | $13.6M | 2021 |
| Cara Therapeutics, Inc. | — | Biotechnology | Series A | $4.9M | $3.6M | 2014 |
| Zappy, Inc. | — | Agriculture | Pre-Seed | $693K | $9.2M | 2014 |
Michael E Lewis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael E Lewis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Lewis | 2 | 12 |
| Stephen Reeders | 1 | 9 |
| Ed Hurwitz | 1 | 9 |
| Amit Kumar | 1 | 8 |
| John W. Brown | 1 | 4 |
| Chris A. Rallis | 1 | 3 |
| Brian Day | 1 | 3 |
| George E. Bye | 1 | 3 |
| Jeffrey L. Ives | 1 | 3 |
| Mark Eidemueller | 1 | 3 |
| Martin Vogelbaum | 1 | 3 |
| JOHN FARAH | 1 | 3 |
| David Cavalier | 1 | 2 |
| Jeffrey M. Jonas | 1 | 2 |
| Michael Hlavsa | 1 | 2 |
| Michael Zapolin | 1 | 2 |
| George Bye | 1 | 2 |
| Russell Skibsted | 1 | 2 |
| Chris Rallis | 1 | 2 |
| Harrison Bains | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.